West Pharmaceutical Services Stock Price Patterns
| WST Stock | USD 237.50 6.38 2.76% |
Momentum 35
Sell Extended
Oversold | Overbought |
Quarterly Earnings Growth 0.038 | EPS Estimate Next Quarter 1.7807 | EPS Estimate Current Year 7.0973 | EPS Estimate Next Year 7.7543 | Wall Street Target Price 345.7143 |
Using West Pharmaceutical hype-based prediction, you can estimate the value of West Pharmaceutical Services from the perspective of West Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards West Pharmaceutical using West Pharmaceutical's stock options and short interest. It helps to benchmark the overall future attitude of investors towards West using crowd psychology based on the activity and movement of West Pharmaceutical's stock price.
West Pharmaceutical Short Interest
An investor who is long West Pharmaceutical may also wish to track short interest. As short interest increases, investors should be becoming more worried about West Pharmaceutical and may potentially protect profits, hedge West Pharmaceutical with its derivative instruments, or be ready for some potential downside.
200 Day MA 247.1174 | Short Percent 0.035 | Short Ratio 2.8 | Shares Short Prior Month 2.1 M | 50 Day MA 267.3486 |
West Pharmaceutical Hype to Price Pattern
Investor biases related to West Pharmaceutical's public news can be used to forecast risks associated with an investment in West. The trend in average sentiment can be used to explain how an investor holding West can time the market purely based on public headlines and social activities around West Pharmaceutical Services. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of West Pharmaceutical's market sentiment to its price can help taders to make decisions based on the overall investors consensus about West Pharmaceutical.
West Pharmaceutical Implied Volatility | 0.65 |
West Pharmaceutical's implied volatility exposes the market's sentiment of West Pharmaceutical Services stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if West Pharmaceutical's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that West Pharmaceutical stock will not fluctuate a lot when West Pharmaceutical's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in West Pharmaceutical to buy its stock at a price that has no basis in reality. In that case, they are not buying West because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
West Pharmaceutical after-hype prediction price | USD 237.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current West contract
Based on the Rule 16, the options market is currently suggesting that West Pharmaceutical Services will have an average daily up or down price movement of about 0.0406% per day over the life of the 2026-03-20 option contract. With West Pharmaceutical trading at USD 237.5, that is roughly USD 0.0965 . If you think that the market is fully incorporating West Pharmaceutical's daily price movement you should consider acquiring West Pharmaceutical Services options at the current volatility level of 0.65%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out West Pharmaceutical Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of West Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
West Pharmaceutical After-Hype Price Density Analysis
As far as predicting the price of West Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in West Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of West Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
West Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting West Pharmaceutical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on West Pharmaceutical's historical news coverage. West Pharmaceutical's after-hype downside and upside margins for the prediction period are 235.51 and 239.49, respectively. We have considered West Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
West Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of West Pharmaceutical is based on 3 months time horizon.
West Pharmaceutical Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as West Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading West Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with West Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.29 | 1.99 | 2.71 | 0.45 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
237.50 | 237.50 | 0.00 |
|
West Pharmaceutical Hype Timeline
On the 2nd of February West Pharmaceutical is traded for 237.50. The entity has historical hype elasticity of -2.71, and average elasticity to hype of competition of 0.45. West is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 21.33%. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.29%. %. The volatility of related hype on West Pharmaceutical is about 128.39%, with the expected price after the next announcement by competition of 237.95. About 98.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.94. West Pharmaceutical recorded earning per share (EPS) of 6.7. The entity last dividend was issued on the 28th of January 2026. The firm had 2:1 split on the 27th of September 2013. Considering the 90-day investment horizon the next projected press release will be in about 10 days. Check out West Pharmaceutical Basic Forecasting Models to cross-verify your projections.West Pharmaceutical Related Hype Analysis
Having access to credible news sources related to West Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict West Pharmaceutical's future price movements. Getting to know how West Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how West Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| WAT | Waters | 1.84 | 6 per month | 0.92 | 0.06 | 3.35 | (1.83) | 8.85 | |
| DGX | Quest Diagnostics Incorporated | 1.26 | 11 per month | 1.10 | 0.01 | 2.68 | (1.96) | 6.29 | |
| HOLX | Hologic | (0.42) | 6 per month | 0.07 | (0.22) | 0.32 | (0.23) | 1.03 | |
| ZBH | Zimmer Biomet Holdings | (0.50) | 8 per month | 0.00 | (0.11) | 2.92 | (2.20) | 18.45 | |
| ILMN | Illumina | (0.97) | 5 per month | 1.50 | 0.15 | 4.19 | (2.87) | 28.04 | |
| LH | Laboratory of | 7.35 | 8 per month | 1.28 | 0.01 | 2.71 | (2.07) | 5.89 | |
| MEDP | Medpace Holdings | (0.97) | 14 per month | 1.53 | (0.01) | 3.02 | (2.31) | 10.01 | |
| INCY | Incyte | 2.29 | 10 per month | 1.75 | 0.06 | 4.10 | (2.92) | 14.33 | |
| COO | The Cooper Companies | 0.26 | 9 per month | 1.09 | 0.08 | 2.84 | (2.03) | 10.26 | |
| STE | STERIS plc | 5.36 | 8 per month | 1.07 | 0.07 | 1.91 | (1.83) | 10.91 |
West Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine West price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for West using various technical indicators. When you analyze West charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About West Pharmaceutical Predictive Indicators
The successful prediction of West Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as West Pharmaceutical Services, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of West Pharmaceutical based on analysis of West Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to West Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to West Pharmaceutical's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.002179 | 0.002472 | 0.002842 | 0.0027 | Price To Sales Ratio | 8.87 | 8.27 | 7.44 | 7.81 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.